Dashboard Systems: Implementing Pharmacometrics from Bench to Bedside
- 20 June 2014
- journal article
- review article
- Published by Springer Nature in The AAPS Journal
- Vol. 16 (5) , 925-937
Abstract
In recent years, there has been increasing interest in the development of medical decision-support tools, including dashboard systems. Dashboard systems are software packages that integrate information and calculations about therapeutics from multiple components into a single interface for use in the clinical environment. Given the high cost of medical care, and the increasing need to demonstrate positive clinical outcomes for reimbursement, dashboard systems may become an important tool for improving patient outcome, improving clinical efficiency and containing healthcare costs. Similarly the costs associated with drug development are also rising. The use of model-based drug development (MBDD) has been proposed as a tool to streamline this process, facilitating the selection of appropriate doses and making informed go/no-go decisions. However, complete implementation of MBDD has not always been successful owing to a variety of factors, including the resources required to provide timely modeling and simulation updates. The application of dashboard systems in drug development reduces the resource requirement and may expedite updating models as new data are collected, allowing modeling results to be available in a timely fashion. In this paper, we present some background information on dashboard systems and propose the use of these systems both in the clinic and during drug development.Keywords
This publication has 44 references indexed in Scilit:
- Development of an Expert System as a Diagnostic Support of Cervical Cancer in Atypical Glandular Cells, Based on Fuzzy Logics and Image InterpretationComputational and Mathematical Methods in Medicine, 2013
- Rational development and utilization of antibody-based therapeutic proteins in pediatricsPharmacology & Therapeutics, 2013
- American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical TrialsAnnals of the Rheumatic Diseases, 2011
- Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practicePediatric Anesthesia, 2011
- Benefits, challenges and obstacles of adaptive clinical trial designsOrphanet Journal of Rare Diseases, 2011
- A knowledge-based taxonomy of critical factors for adopting electronic health record systems by physicians: a systematic literature reviewBMC Medical Informatics and Decision Making, 2010
- Computerized Decision Support for EPO Dosing in Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2009
- Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug DevelopmentThe AAPS Journal, 2008
- Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapyBMC Medical Informatics and Decision Making, 2008
- COBRA combination therapy in patients with early rheumatoid arthritis: Long‐term structural benefits of a brief interventionArthritis & Rheumatism, 2002